Bevacizumab for Cervical Cancer

Clinical Pearls

Bradley Monk, MD, gynecologic oncologist, University of Arizona Cancer Center Phoenix Branch, discusses the utility of bevacizumab for the treatment of cervical cancer.

• Bevacizumab has been looked at in many solid tumors, including ovarian cancer.
• Treatment options for patients with cervical cancer are limited.
• Bevacizumab plus chemotherapy elicits a survival advantage in this population.

MORE: Bevacizumab Receives Priority Review for Advanced Cervical Cancer > >